Agile Therapeutics, Inc. (AGRX)
Aug 26, 2024 - AGRX was delisted (reason: acquired by Insud Pharma)
1.510
0.00 (0.00%)
Inactive · Last trade price on Aug 26, 2024
Agile Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 | Mar '21 Mar 31, 2021 | Dec '20 Dec 31, 2020 | Sep '20 Sep 30, 2020 | Jun '20 Jun 30, 2020 | Mar '20 Mar 31, 2020 | Dec '19 Dec 31, 2019 | Sep '19 Sep 30, 2019 |
| 5.58 | 5.72 | 3.61 | 6.66 | 5.5 | 3.81 | 4 | 3 | 2.13 | 1.76 | 1.51 | 1.29 | 1.19 | 0.12 | 0.75 | - | - | - | - | - | |
Revenue Growth (YoY) | 1.33% | 49.91% | -9.56% | 121.92% | 158.84% | 116.52% | 163.94% | 133.26% | 79.41% | 1418.10% | 102.14% | - | - | - | - | - | - | - | - | - |
Cost of Revenue | 1.5 | 1.68 | 2.19 | 2.48 | 2.31 | 2 | 1.65 | 1.43 | 2.23 | 1.53 | 5.7 | 2.71 | 1.15 | 1.16 | 0.28 | - | - | - | - | - |
Gross Profit | 4.08 | 4.04 | 1.42 | 4.18 | 3.2 | 1.81 | 2.34 | 1.58 | -0.11 | 0.23 | -4.19 | -1.42 | 0.04 | -1.05 | 0.47 | - | - | - | - | - |
Selling, General & Admin | 6.29 | 6.3 | 5.42 | 7.48 | 7.62 | 7.76 | 8.87 | 8.38 | 10.44 | 14.55 | 16.49 | 12.76 | 15.83 | 13.05 | 14.2 | 10.99 | 6.38 | 4.45 | 3.27 | 2.14 |
Research & Development | 0.54 | 0.5 | 0.05 | 0.71 | 0.7 | 0.76 | 0.35 | 0.79 | 0.86 | 1.26 | 1.68 | 1.59 | 0.86 | 2.12 | 3.01 | 3.66 | 3.66 | 3.16 | 2.84 | 2.36 |
Operating Expenses | 6.83 | 6.79 | 5.48 | 8.19 | 8.32 | 8.52 | 9.22 | 9.16 | 11.29 | 15.81 | 18.17 | 14.35 | 16.69 | 15.18 | 17.21 | 14.66 | 10.04 | 7.62 | 6.11 | 4.5 |
Operating Income | -2.75 | -2.76 | -4.05 | -4 | -5.13 | -6.71 | -6.88 | -7.59 | -11.4 | -15.57 | -22.36 | -15.77 | -16.65 | -16.22 | -16.74 | -14.66 | -10.04 | -7.62 | -6.11 | -4.5 |
Interest Expense | - | -0.19 | -0.31 | -0.34 | -0.37 | -0.4 | -0.43 | -1 | -0.82 | -0.87 | -1 | -1 | -0.99 | -0.92 | -0.9 | -0.91 | -0.9 | -0.4 | - | - |
Interest & Investment Income | 0.03 | 0.02 | 0.02 | 0.01 | 0.02 | 0.03 | 0.03 | 0.05 | 0 | 0 | 0 | 0 | 0.01 | 0.02 | 0.03 | 0.04 | 0.12 | 0.13 | 0.08 | 0.07 |
Other Non Operating Income (Expenses) | -9.15 | 4.2 | -0.13 | 3.53 | 1.67 | 1.69 | 3.35 | 13.74 | 7.05 | 1.38 | 3.83 | - | - | - | - | - | - | - | - | - |
EBT Excluding Unusual Items | -11.87 | 1.28 | -4.47 | -0.8 | -3.81 | -5.39 | -3.93 | 5.19 | -5.17 | -15.06 | -19.53 | -16.77 | -17.64 | -17.13 | -17.62 | -15.52 | -10.83 | -7.88 | -6.02 | -4.43 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | - | - | -11.12 | - | - | - | - | - | - | - | - | - | - | - | - |
Pretax Income | -11.87 | 1.28 | -4.47 | -0.8 | -3.81 | -5.39 | -3.93 | -5.93 | -5.17 | -15.06 | -19.53 | -16.77 | -17.64 | -17.13 | -17.62 | -15.52 | -10.83 | -7.88 | -6.02 | -4.43 |
Income Tax Expense | - | - | - | - | - | - | - | - | - | -4.68 | - | - | - | - | - | - | - | - | - | - |
Net Income | -11.87 | 1.28 | -4.47 | -0.8 | -3.81 | -5.39 | -3.93 | -5.93 | -5.17 | -10.39 | -19.53 | -16.77 | -17.64 | -17.13 | -17.62 | -15.52 | -10.83 | -7.88 | -6.02 | -4.43 |
Net Income to Common | -11.87 | 1.28 | -4.47 | -0.8 | -3.81 | -5.39 | -3.93 | -5.93 | -5.17 | -10.39 | -19.53 | -16.77 | -17.64 | -17.13 | -17.62 | -15.52 | -10.83 | -7.88 | -6.02 | -4.43 |
Net Income Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding (Basic) | 7 | 5 | 3 | 3 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shares Outstanding (Diluted) | 7 | 5 | 3 | 3 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shares Change (YoY) | 287.40% | 407.86% | 259.38% | 298.69% | 1862.00% | 1363.86% | 1298.69% | 1478.44% | 103.40% | 42.20% | 34.84% | 7.34% | 1.69% | 14.32% | 39.78% | 62.94% | 99.25% | 105.46% | 81.98% | 55.94% |
EPS (Basic) | -1.73 | 0.28 | -1.51 | -0.27 | -2.15 | -5.91 | -4.77 | -8.01 | -57.29 | -166.68 | -331.25 | -357.77 | -397.70 | -390.93 | -402.98 | -355.44 | -248.24 | -205.68 | -192.49 | -165.34 |
EPS (Diluted) | -1.73 | 0.28 | -1.51 | -0.27 | -2.15 | -5.91 | -4.77 | -8.01 | -57.29 | -166.68 | -331.25 | -357.77 | -397.70 | -390.93 | -402.98 | -360.00 | -248.24 | -205.68 | -192.49 | -165.34 |
EPS Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Additional Metrics
Fiscal Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 | Mar '21 Mar 31, 2021 | Dec '20 Dec 31, 2020 | Sep '20 Sep 30, 2020 | Jun '20 Jun 30, 2020 | Mar '20 Mar 31, 2020 | Dec '19 Dec 31, 2019 | Sep '19 Sep 30, 2019 |
Free Cash Flow | 0.23 | -2.48 | 0.17 | 0.37 | -8.52 | -1.6 | -1.56 | -16.7 | -2.94 | -14.88 | -16.67 | -18.65 | -15.41 | -14.74 | -17.4 | -15.39 | -6.82 | -8.05 | -3.34 | -5.11 |
Free Cash Flow Per Share | 0.03 | -0.53 | 0.06 | 0.12 | -4.81 | -1.75 | -1.89 | -22.57 | -32.60 | -238.78 | -282.79 | -397.73 | -347.58 | -336.41 | -397.93 | -352.47 | -156.45 | -209.99 | -106.71 | -190.64 |
Gross Margin | 73.17% | 70.61% | 39.37% | 62.82% | 58.08% | 47.47% | 58.63% | 52.53% | -4.94% | 13.29% | -276.55% | -110.64% | 3.38% | - | 62.35% | - | - | - | - | - |
Operating Margin | -49.25% | -48.23% | -112.12% | -60.04% | -93.15% | -175.92% | -172.12% | -252.70% | -536.12% | -884.33% | -1476.75% | -1225.64% | -1405.15% | -13984.48% | -2235.11% | - | - | - | - | - |
Profit Margin | -212.91% | 22.46% | -123.69% | -11.99% | -69.22% | -141.36% | -98.37% | -197.53% | -243.09% | -589.72% | -1289.96% | -1303.19% | -1488.35% | -14765.52% | -2352.47% | - | - | - | - | - |
Free Cash Flow Margin | 4.18% | -43.32% | 4.76% | 5.48% | -154.81% | -41.83% | -39.01% | -556.40% | -138.33% | -844.80% | -1101.25% | -1448.72% | -1300.76% | -12706.03% | -2322.96% | - | - | - | - | - |
EBITDA | -2.64 | -2.65 | -3.95 | -3.9 | -5.03 | -6.62 | -6.79 | -7.32 | -10.81 | -14.99 | -21.78 | -15.22 | -16.1 | -15.68 | -16.61 | -14.6 | -9.99 | -7.57 | -6.06 | -4.46 |
EBITDA Margin | -47.42% | -46.43% | -109.35% | -58.57% | -91.42% | -173.49% | -169.84% | -243.97% | - | - | - | - | - | - | - | - | - | - | - | - |
D&A For EBITDA | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.09 | 0.09 | 0.26 | 0.59 | 0.59 | 0.58 | 0.55 | 0.55 | 0.55 | 0.13 | 0.06 | 0.05 | 0.04 | 0.04 | 0.04 |
EBIT | -2.75 | -2.76 | -4.05 | -4 | -5.13 | -6.71 | -6.88 | -7.59 | -11.4 | -15.57 | -22.36 | -15.77 | -16.65 | -16.22 | -16.74 | -14.66 | -10.04 | -7.62 | -6.11 | -4.5 |
EBIT Margin | -49.25% | -48.23% | -112.12% | -60.04% | -93.15% | -175.92% | -172.12% | -252.70% | - | - | - | - | - | - | - | - | - | - | - | - |
Advertising Expenses | - | - | - | - | - | - | - | 0.9 | 1.9 | 3.3 | - | 2.7 | 3 | 3.1 | - | - | - | - | - | - |